Medpace Holdings Inc (MEDP)
Debt-to-assets ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total assets | US$ in thousands | 2,100,870 | 1,656,830 | 1,352,500 | 1,659,940 | 1,390,680 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $2,100,870K
= 0.00
The debt-to-assets ratio of Medpace Holdings Inc has consistently remained at 0.00 over the five-year period from December 31, 2020, to December 31, 2024. This indicates that the company has not utilized any debt to finance its assets during this period, suggesting a conservative approach to capital structure and financial risk management. A debt-to-assets ratio of 0.00 implies that all the firm's assets are financed through equity or internal funds, reflecting a strong financial position and potentially reducing the company's financial risks associated with debt obligations.
Peer comparison
Dec 31, 2024
Company name
Symbol
Debt-to-assets ratio
Medpace Holdings Inc
MEDP
0.00
Arrowhead Pharmaceuticals Inc
ARWR
0.34
Charles River Laboratories
CRL
0.00
Exelixis Inc
EXEL
0.00
Incyte Corporation
INCY
0.00
IQVIA Holdings Inc
IQV
0.48